Benzinga | May 14, 2021 07:38AM EDT

Morgan Stanley Maintains Equal-Weight on Haemonetics, Lowers Price Target to $75

Morgan Stanley maintains Haemonetics (NYSE:HAE) with a Equal-Weight and lowers the price target from $83 to $75.